1. Kubo K, Azuma A, Kanazawa M, Kameda H, Kusumoto M, Genma A, Saijo Y, Sakai F, Sugiyama Y, Tatsumi K, Dohi M, Tokuda H, Hashimoto S, Hattori N, Hanaoka M, Fukuda Y, Japanese Respiratory Society Committee for formulation of Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Invest. 2013;51(4):260–77.
2. Yokoyama A. Approach to the diagnosis of drug-induced lung diseases. Nihon Naika Gakkai Zasshi. 2007;96(6):1097–103.
3. Japanese Respiratory Society Committee for formulation of the guide for the Biological agents and respiratory diseases: Guide for the medical treatment. Biological agents and respiratory diseases: Guide for the medical treatment. 2014. http://www.jrs.or.jp/modules/guidelines/index.php?content_id=69 .
4. Hirata S, Hattori N, Kumagai K, Haruta Y, Yokoyama A, Kohno N. Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis. Clin Chim Acta. 2009;407(1–2):25–9.
5. Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132(5):1652–8.